AzTrials
AzTrials

HealthyNCT01415973

Nutrient Synergy in Beef and Stimulation of Protein Synthesis in Elderly

A study testing 3 ounces of cooked, 85% lean ground beef and 20 grams beef protein isolate in people with Healthy, run by University of Arkansas at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will compare the effects of cooked, ground beef to those of beef protein isolate on blood and muscle proteins. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
3 ounces of cooked, 85% lean ground beef and 20 grams beef protein isolate
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
Jul 2011to Jan 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy male or female.
  • Age 60 years or older.

Who cannot join

  • Any (history of) gastrointestinal disease that interferes with GI function
  • Diagnosed and active treatment of Diabetes Mellitus type I or II
  • History of congestive heart failure
  • Recent (6 months) hospitalization for heart disease treatment or management (e.g. PTCA, stent, surgery)
  • Myocardial infarction in the past year
  • Infection or fever in the 7 days prior to enrollment
Show all 16Show fewer
  • Current use of corticosteroids, growth hormone, or testosterone
  • Adherence to a weight loss diet
  • Use of protein-containing or amino acid-containing nutritional supplements within one week of enrollment
  • Current alcohol (>7 ETOH per week) or drug abuse
  • Platelet count (PLT) < 100,000
  • History of hypo- or hyper-coagulation disorders including use of a coumadin derivative
  • Currently taking anti-thrombotics and cannot stop for 7 days (i.e. medical indication)
  • Allergy to local anesthetic
  • Blood hemoglobin < 9.0 g/dL
  • Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UAMS Center on Aging

    Little Rock, Arkansas, 72205

Other trials in United States

About this study

This study will compare the effects of cooked, ground beef to those of beef protein isolate on blood and muscle proteins.

Read the detailed description

STUDY OBJECTIVES Primary: To compare the effects of consumption of a 3-ounce serving of beef to that of a 20g serving of BPI on skeletal muscle synthetic and breakdown rate in healthy elderly subjects.

Secondary: To investigate the effect the study products on plasma levels of amino acids, insulin, and glucose in healthy elderly subjects.

Conditions
Healthy
Being tested
3 ounces of cooked, 85% lean ground beef, 20 grams beef protein isolate
Keywords
beef, protein, synergy, intact beef constituents, protein constituent, Nutrient Synergy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3 ounces of cooked, 85% lean ground beefDietary supplement

    Consumed once per subject.

  • 20 grams beef protein isolateDietary supplement

    Subjects would drink 200 ml water mixed with 20 grams of beef protein isolate one time.

Study groups in NCT01415973
Study groupRoleWhat they receive
3 ounces of cooked, 85% lean ground beefExperimentalSubjects would consume 3 ounces of cooked, 85% lean ground beef at one setting on one day.
Receives: Dietary Supplement: 3 ounces of cooked, 85% lean ground beef
20 grams of Beef protein isolateExperimentalSubjects would consume 20 grams of beef protein isolate dissolved into 200mL water at one setting on one day.
Receives: Dietary Supplement: 20 grams beef protein isolate

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. skeletal muscle synthetic and breakdown rate

    Using stable isotope infusion/ingestion methodology, we will measure plasma and skeletal muscle metabolic rate. Our primary end points will be muscle protein fractional synthesis rate (FSR) and whole body protein turnover rate.

    Measured: day one

Secondary outcomes (1)
  1. concentrations of plasma amino acids, insulin and glucose

    Secondary endpoints are concentrations of plasma amino acids, insulin and glucose.

    Measured: day one

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2011 (estimated)
  2. Study startJul 2011
  3. Primary completionSep 2011
  4. Study completionJan 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01415973
Sponsor's protocol ID
UAMS IRB #132559
Status last verified
Jan 2012
First submitted
10 Aug 2011
Last updated
18 Jan 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing 3 ounces of cooked, 85% lean ground beef and 20 grams beef protein isolate in people with Healthy, run by University of Arkansas at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jan 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

skeletal muscle synthetic and breakdown rate (time frame: day one). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in